Febulas 40 mg (Tablet)

Unit Price: ৳ 8.00 (3 x 10: ৳ 240.00)
Strip Price: ৳ 80.00

Medicine Details

Category Details
Generic Febuxostat
Company Delta pharma ltd

Therapeutic Class

  • Drugs used in Gout

Indications

  • Chronic management of hyperuricemia in patients with gout

Pharmacology

  • Febuxostat is a non-purine, selective xanthine oxidase (XO) inhibitor
  • Decreases serum uric acid level by inhibiting xanthine oxidase

Dosage & Administration

  • Recommended starting dose of Febuxostat 40 mg tablet once daily
  • For patients not achieving serum uric acid less than 6 mg per dL after 2 weeks, 80 mg tablet once daily is recommended
  • For patients not achieving serum uric acid less than 6 mg per dL after 2-4 weeks with 80mg tablet, then 120 mg tablet once daily is recommended
  • Dose for Tumor Lysis Syndrome is one 120 mg tablet once daily
  • Gout flares management with non-steroidal anti-inflammatory drug (NSAID) or colchicine is recommended
  • No dose adjustment necessary in patients with mild to moderate renal impairment
  • No dose adjustment necessary in patients with mild to moderate hepatic impairment
  • Safety and effectiveness in pediatric patients under 18 years of age have not been established

Interaction

  • Concomitant use of Mercaptopurine/Azathioprine not recommended
  • Co-administration with rosiglitazone or other CYP2C8 substrates is not expected to require dose adjustment
  • No dose adjustment necessary for co-administration with naproxen, colchicine, indomethacin, hydrochlorothiazide, or warfarin
  • Concomitant ingestion of antacid containing magnesium hydroxide and aluminum hydroxide may cause delayed absorption of Febuxostat

Contraindications

  • Contraindicated in patients being treated with azathioprine, mercaptopurine, or theophylline

Side Effects

  • Most commonly reported adverse reactions are gout flares, liver function abnormalities, diarrhea, nausea, headache, rash, and edema

Pregnancy & Lactation

  • Pregnancy Category C
  • Caution should be exercised when administered to a nursing woman

Precautions & Warnings

  • Increased gout flares observed during initiation of treatment
  • Higher rate of cardiovascular thromboembolic events observed in patients treated with Febuxostat
  • Monitor liver function tests periodically

Overdose Effects

  • Febustat studied in healthy subjects in doses up to 300 mg daily for seven days without evidence of dose-limiting toxicities

Storage Conditions

  • Keep below 30°C temperature, away from light & moisture
  • Keep out of the reach of children

Related Brands